Cargando…
Use of intravenous antiarrhythmics to identify concealed Brugada syndrome
Cardiology has recently witnessed the production of an overwhelming amount of data through the advances made in genetics and molecular biology research. Understanding of genetics has tremendous potential to aid in the prevention, diagnosis and treatment of the majority of diseases. Despite the high...
Autor principal: | Brugada, Ramon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59598/ https://www.ncbi.nlm.nih.gov/pubmed/11714408 http://dx.doi.org/10.1186/cvm-1-1-045 |
Ejemplares similares
-
Genetic and Molecular Mechanisms in Brugada Syndrome
por: Moras, Errol, et al.
Publicado: (2023) -
Concealed Substrates in Brugada Syndrome: Isolated Channelopathy or Associated Cardiomyopathy?
por: Di Resta, Chiara, et al.
Publicado: (2022) -
Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
por: Campuzano, Oscar, et al.
Publicado: (2020) -
Experimental Models of Brugada syndrome
por: Sendfeld, Franziska, et al.
Publicado: (2019) -
Antiarrhythmic Effect of Artemisinin in an Ex-vivo Model of Brugada Syndrome Induced by NS5806
por: Jeong, Hyung Ki, et al.
Publicado: (2023)